Cavorsi Robert 4

What Happened
Robert Cavorsi, Vice President, Strategy at Organogenesis (ORGO), had a total of 17,658 shares disposed/withheld on February 15, 2026 to satisfy tax or exercise-related obligations. The transactions were three withholdings: 6,667 shares at $3.73 ($24,868), 5,549 shares at $3.73 ($20,698), and 5,442 shares at $3.73 ($20,299), totaling $65,865. These are tax/withholding dispositions (transaction code F), not open-market purchases or voluntary sales.

Key Details

• Transaction date: 2026-02-15; Form 4 filed: 2026-02-18 (filed within the Form 4 deadline given the holiday/weekend timing).
• Price per share reported: $3.73.
• Shares withheld/disposed: 6,667; 5,549; 5,442 — total 17,658 shares; total value reported: $65,865.
• Transaction code: F — payment of exercise price or tax liability (share withholding).
• Shares owned after the transaction: not specified in the provided summary — see the full Form 4 for Cavorsi’s post-transaction holdings.
• No 10b5-1 or other plan noted in the supplied data.

Context
Code F transactions typically mean the company withheld shares to cover taxes or exercise costs associated with an option exercise or restricted stock vesting. This is a routine, administrative disposition (often part of a cashless exercise or tax withholding) and does not equate to an open-market sale that signals intent to trade shares. For full details and Cavorsi’s remaining holdings, consult the complete SEC Form 4 filing (Accession: 0002064832-26-000029).